Literature DB >> 18245400

Pepsin, a marker of gastric contents, is increased in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia.

Sabeena Farhath1, Zhaoping He, Tarek Nakhla, Judy Saslow, Sam Soundar, Jeanette Camacho, Gary Stahl, Stephen Shaffer, Devendra I Mehta, Zubair H Aghai.   

Abstract

OBJECTIVE: The objective of this study was to study the association between pepsin in tracheal aspirate samples and the development of bronchopulmonary dysplasia in preterm infants.
METHODS: Serial tracheal aspirate samples were collected during the first 28 days from mechanically ventilated preterm neonates. Bronchopulmonary dysplasia was defined as the need for supplemental oxygen at 36 weeks' postmenstrual age. An enzymatic assay with a fluorescent substrate was used to detect pepsin. Total protein was measured by the Bradford assay to correct for the dilution during lavage. Immunohistochemistry using antibody against human pepsinogen was performed in 10 lung tissue samples from preterm infants.
RESULTS: A total of 256 tracheal aspirate samples were collected from 59 preterm neonates. Pepsin was detected in 234 (91.4%) of 256 of the tracheal aspirate samples. Twelve infants had no bronchopulmonary dysplasia, 31 infants developed bronchopulmonary dysplasia, and 16 infants died before 36 weeks' postmenstrual age. The mean pepsin concentration was significantly lower in infants with no bronchopulmonary dysplasia compared with those who developed bronchopulmonary dysplasia or developed bronchopulmonary dysplasia/died before 36 weeks' postmenstrual age. Moreover, the mean pepsin level was significantly higher in infants with severe bronchopulmonary dysplasia compared with moderate bronchopulmonary dysplasia. The mean pepsin level in tracheal aspirate samples from the first 7 days was also lower in infants with no bronchopulmonary dysplasia compared with those who developed bronchopulmonary dysplasia or developed bronchopulmonary dysplasia/died before 36 weeks' postmenstrual age. Pepsinogen was not localized in the lung tissues by immunohistochemistry.
CONCLUSION: The concentration of pepsin was increased in the tracheal aspirate of preterm infants who developed bronchopulmonary dysplasia or died before 36 weeks' postmenstrual age. Recovery of pepsin in tracheal aspirate samples is secondary to gastric aspiration, not by hematogenous spread or local synthesis in the lungs. Chronic aspiration of gastric contents may contribute in the pathogenesis of bronchopulmonary dysplasia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18245400     DOI: 10.1542/peds.2007-0056

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  19 in total

1.  The presence of pepsin in the lung and its relationship to pathologic gastro-esophageal reflux.

Authors:  R Rosen; N Johnston; K Hart; U Khatwa; S Nurko
Journal:  Neurogastroenterol Motil       Date:  2011-12-05       Impact factor: 3.598

2.  Preliminary study in to the incidence of gastroesophageal reflux (GER) in high risk neonates admitted to NICU.

Authors:  Vivek Kumar; S S Mathai; M Kanitkar
Journal:  Indian J Pediatr       Date:  2011-10-15       Impact factor: 1.967

3.  Anti-gastroesophageal reflux surgery in infants with severe bronchopulmonary dysplasia.

Authors:  Erik A Jensen; David A Munson; Huayan Zhang; Thane A Blinman; Haresh Kirpalani
Journal:  Pediatr Pulmonol       Date:  2014-04-21

Review 4.  Biomarkers in the diagnosis of aspiration syndromes.

Authors:  Philippe Abou Jaoude; Paul R Knight; Patricia Ohtake; Ali A El-Solh
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

5.  Individualising care in severe bronchopulmonary dysplasia: a series of N-of-1 trials comparing transpyloric and gastric feeding.

Authors:  Erik A Jensen; Huayan Zhang; Rui Feng; Kevin Dysart; Kathleen Nilan; David A Munson; Haresh Kirpalani
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2019-11-04       Impact factor: 5.747

6.  Characterization of Disease Phenotype in Very Preterm Infants with Severe Bronchopulmonary Dysplasia.

Authors:  Katherine Y Wu; Erik A Jensen; Ammie M White; Yan Wang; David M Biko; Kathleen Nilan; María V Fraga; Laura Mercer-Rosa; Huayan Zhang; Haresh Kirpalani
Journal:  Am J Respir Crit Care Med       Date:  2020-06-01       Impact factor: 21.405

7.  Sep70/Pepsin expression in hypopharynx combined with hypopharyngeal multichannel intraluminal impedance increases diagnostic sensitivity of laryngopharyngeal reflux.

Authors:  Toshitaka Hoppo; Ali H Zaidi; Daisuke Matsui; Samantha A Martin; Yoshihiro Komatsu; Emily J Lloyd; Juliann E Kosovec; Albert A Civitarese; Natalie H Boyd; Amit Shetty; Ashten N Omstead; Emily Smith; Blair A Jobe
Journal:  Surg Endosc       Date:  2017-12-20       Impact factor: 4.584

8.  Salivary Pepsin Lacks Sensitivity as a Diagnostic Tool to Evaluate Extraesophageal Reflux Disease.

Authors:  Fei Dy; Janine Amirault; Paul D Mitchell; Rachel Rosen
Journal:  J Pediatr       Date:  2016-07-21       Impact factor: 4.406

Review 9.  Clinical practice. The impact of lung disease on the heart and cardiac disease on the lungs.

Authors:  Fiona Healy; Brian D Hanna; Raezelle Zinman
Journal:  Eur J Pediatr       Date:  2009-07-29       Impact factor: 3.183

10.  Long-term morbidities associated with vocal cord paralysis after surgical closure of a patent ductus arteriosus in extremely low birth weight infants.

Authors:  J R Benjamin; P B Smith; C M Cotten; J Jaggers; R F Goldstein; W F Malcolm
Journal:  J Perinatol       Date:  2009-09-17       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.